Companies › AVBP

ARRIVENT BIOPHARMA INC (AVBP)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001868279 · EDGAR filings · Updated 2026-07-27

ARRIVENT BIOPHARMA INC (AVBP) has reported institutional ownership of 95.2%, with 139 institutional managers holding positions valued at $969.5M per the latest 13F reporting period.

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-22 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ARRIVENT BIOPHARMA INC has 139 institutional holders and institutional ownership of 95.2%.

Insider activity

Insiders reported 4 transactions (0 buys, 1 sells) across 2 reporting insiders, with a net reported value of −$13.0M.

Related companies

TELADOC HEALTH INC (TDOC) · PACIRA BIOSCIENCES INC COM (PCRX) · CADRE HLDGS INC (CDRE) · NOVAVAX INC (NVAX) · BIOLIFE SOLUTIONS INC COM NEW (BLFS) · FRESENIUS MEDICAL CARE AG (FMS)